Long-term Antiplatelet Management after Complex PCI. Aspirin vs. Clopidogrel
[Speaker] Chan Jun Kim/Catholic Univ., Korea
Do We Have Any Evidence for Long-term Dual Pathway Inhibition in AF Patients Undergoing PCI?
[Speaker] Jee Hoon Kang/Seoul National Univ., Korea
PCSK9 Inhibitor vs. High Potency Statin Plus Ezetimibe in Korean Patients at Very High Risk
[Speaker] Kyung Hoon Cho/Chonnam National Univ., Korea
Optimal Medical Treatment in Cardiogenic Shock Patient Undergoing VA-ECMO
[Speaker] Jeong Hoon Yang/Sungkyunkwan Univ., Korea
Discussion